Lineage Cell Therapeutics, Inc. (LCTX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for LCTX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 127 institutions reported holding LCTX, with 116.4 million shares worth $152.5 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Broadwood Capital | 49,560,992 | $65M | UNCHANGED |
| BlackRock | 13,186,895 | $17M | INCREASED |
| Vanguard | 12,082,653 | $16M | INCREASED |
| Defender Capital, LLC | 6,598,899 | $9M | DECREASED |
| Geode Capital Management | 5,299,457 | $7M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Lineage Cell Therapeutics, Inc. on SentiSense.